Low-dose immune tolerance induction in hemophilia a patients with inhibitorsMAUSER-BUNSCHOTEN, E. P; NIEUWENHUIS, H. K; ROOSENDAAL, G et al.Blood. 1995, Vol 86, Num 3, pp 983-988, issn 0006-4971Article

A patient with acquired haemophilia A and pemphigusHALBERTSMA, F. J. J; VAN DER LINDEN, P. W. G; MAUSER-BUNSCHOTEN, E. P et al.Netherlands journal of medicine. 1998, Vol 52, Num 5, pp 190-192, issn 0300-2977Article

Progression to AIDS in relation to clinical factors and clotting product consumption: A 14-year follow-up of a cohort of 52 dutch HIV-1-infected haemophilic patientsROOSENDAAL, G; VAN DER SCHOUW, Y. T; MAUSER-BUNSCHOTEN, E. P et al.Vox sanguinis (Basel. 1956). 1998, Vol 75, Num 4, pp 261-266, issn 0042-9007Article

Sexual transmission of hepatitis C virusBRESTERS, D; MAUSER-BUNSCHOTEN, E. P; VAN DEN BERG, H. M et al.Lancet (British edition). 1993, Vol 342, Num 8865, pp 210-211, issn 0140-6736Article

Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trialBRESTERS, D; CUYPERS, H. T. M; REESINK, H. W et al.Journal of medical virology. 1994, Vol 43, Num 3, pp 262-268, issn 0146-6615Article

A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in the NetherlandsROSENDAAL, F. R; NIEUWENHUIS, H. K; VAN DEN BERG, H. M et al.Blood. 1993, Vol 81, Num 8, pp 2180-2186, issn 0006-4971Article

Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low doseVAN LEEUWEN, E. F; MAUSER-BUNSCHOTEN, E. P; VAN DIJKEN, P. J et al.British journal of haematology. 1986, Vol 64, Num 2, pp 291-297, issn 0007-1048Article

Long term treatment of chronic hepatitis C with interferon alfa-2b : disappearance of HCV-RNA in a pilot study of eight haemophilia patientsBRESTERS, D; MAUSER-BUNSCHOTEN, E. P; CUYPERS, H. T. M et al.Gut. 1993, Vol 34, Num 2, pp S124-S125, issn 0017-5749, SUPConference Paper

Sensitivity of an anti-HCV core peptide ELISABRESTERS, D; REESINK, H. W; CUYPERS, H. T. M et al.Journal of medical virology. 1992, Vol 37, Num 3, pp 187-191, issn 0146-6615Article

Long-term outcome of individualized prophylactic treatment of children with severe haemophiliaVAN DEN BERG, H. M; FISCHER, K; MAUSER-BUNSCHOTEN, E. P et al.British journal of haematology. 2001, Vol 112, Num 3, pp 561-565, issn 0007-1048Article

Risk of hepatitis A in Dutch hemophilia patientsMAUSER-BUNSCHOTEN, E. P; ZAAIJER, H. L; VAN DRIMMELEN, A. A. J et al.Thrombosis and haemostasis. 1995, Vol 74, Num 2, pp 616-618, issn 0340-6245Article

Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patientsBRESTERS, D; MAUSER-BUNSCHOTEN, E. P; CUYERS, H. T. M et al.Scandinavian journal of gastroenterology. 1992, Vol 27, Num 3, pp 166-168, issn 0036-5521Article